Business
MustGrow Provides 2024 Pipeline Update
MustGrow transitions from R&D to commercialization. TerraSante TM biofertility produc...
About this update from Mustgrow Biologics Corp.
[{"type":"text","content":"MustGrow Provides 2024 Pipeline UpdateMustGrow transitions from R&D to commercialization.TerraSanteTM biofertility product manufacturing and sales has commenced, with potential initial sales ramp-up in 2025 and 2026.Commercialization of TerraMGTM soil biopesticide is progressing under the Bayer commercial agreement in the EU, Middle East and Africa.Registration work for TerraMGTM soil biopesticide continues in the U.S. and Canada.Expiration of exclusive non-commercial agreements.Intellectual property portfolio continues to grow. Management presentation and Q&A set for Tuesday September 24, 2024.Saskatoon, Saskatchewan--(Newsfile Corp. - September 23, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the \"Company\" or \"MustGrow\") is pleased to provide its 2024 pipeline update. The Company is a leader in innovative biological nutrition and crop protection solutions from mustard and today announced significant developments in the commercialization of its flagship products, TerraSanteTM and TerraMGTM, as the Company advances its efforts to transform sustainable agriculture.TerraSanteTM: Initial Sales and Market OpportunityMustGrow is pleased to announce that TerraSanteTM is in the initial stages of commercialization, with product registration successfully obtained in key high value crop growing U.S. states, including California, Florida, Arizona, Idaho, Oregon, and Washington. The Company is receiving purchase orders and sales have commenced, marking a major milestone for the Company.To assist in executing the direct sales and marketing strategy in the U.S., MustGrow engaged the services of two key industry veterans, Tim Lichatowich and Mike Atkins, who have close to six decades of combined experience in the fruit, vegetable and row crop markets.\"We are seeing strong initial interest in TerraSanteTM, particularly in California, where the market demand for a product like MustGrow's is significant,\" said Mike Atkins. Tim Lichatowich, who led multiple grower and industry meetings in California throughout 2024 also commented, \"The potential for TerraSanteTM is even greater than we anticipated, with opportunity for multiple applications per year over large acreages.\"Key highlights of TerraSanteTM's market progress include:Initial Sales: Sales have commenced in the U.S., following registrations in sev...